Top Gun: Maverick & Mission: Impossible 7 Delayed Yet Again

Tom Cruise is part of two highly anticipated movies, but the wait to see them has gotten a bit longer. While he’s extremely happy to do his own stunts, he also love doing them so much that he can’t stop smiling while doing them. The sudden announcement of Top Gun: Maverick made very excited. However, while it was about to make a return for the American audiences on July 4th, it instead got reshuffled to November 19.

While the release date for Mission Impossible 7 was scheduled to be released on November 19th, it has gotten a more longer delay, where fans would be able to watch next year on the release date of May 27, 2022.

Paramount issued a statement to Deadline where it explained that why they decided to redo the scheduled of the movies:

Top Gun: Maverick stands to be a billion-dollar grossing movie and Paramount isn’t going to let one buck of that slip away. Exhibition continues to be closed in Europe (with UK eyeing a May 17 reopening) and Brazil as they continue to grapple with Covid, and it’s going to take time for those markets to get back in shape. A late November date stands a better chance of Europe and Brazil being fully open for Top Gun: Maverick.

Advertising

Advertising

Paramount president Chris Aronson even confidently said that Top Gun’s sequel would under no circumstance would get delayed and there are good reasons for that. He told Hollywood Reporter:

We have no plans to move our theatrical release of Top Gun. I think the next two months are critical, and whether the new administration can implement a robust vaccination plan. If Biden’s 100 million vaccines in 100 days works, then I think we’ll be in good shape.

Since the Biden Administration got the goal of 100 million shots fulfilled just 58 days after vaccine distribution had begun, they plan on doubling the number before the 100 days even complete.

It seems that now Paramount has refocused their motivation, and now they want as large as an audience they can possibly get in the theaters for its highly anticipated product.